IDEXX Laboratories Inc. (IDXX)
NASDAQ: IDXX
· Real-Time Price · USD
471.27
38.62 (8.93%)
At close: May 01, 2025, 12:31 PM
8.93% (1D)
| Bid | 471.17 |
| Market Cap | 38.19B |
| Revenue (ttm) | 3.9B |
| Net Income (ttm) | 887.87M |
| EPS (ttm) | 10.69 |
| PE Ratio (ttm) | 44.09 |
| Forward PE | 31.9 |
| Analyst | Buy |
| Ask | 471.78 |
| Volume | 703,985 |
| Avg. Volume (20D) | 946,201 |
| Open | 468.18 |
| Previous Close | 432.65 |
| Day's Range | 462.05 - 481.93 |
| 52-Week Range | 356.14 - 548.88 |
| Beta | 1.50 |
About IDXX
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic an...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jun 21, 1991
Employees 11,000
Stock Exchange NASDAQ
Ticker Symbol IDXX
Website https://www.idexx.com
Analyst Forecast
According to 8 analyst ratings, the average rating for IDXX stock is "Buy." The 12-month stock price forecast is $535, which is an increase of 13.52% from the latest price.
Stock ForecastsEarnings Surprise
IDEXX Laboratories has released their quartely earnings
on May 1, 2025:
Next Earnings Release
IDEXX Laboratories Inc. is scheduled to release its earnings on May 1, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+11.13%
IDEXX Laboratories shares are trading higher after...
Unlock content with
Pro Subscription
6 months ago
-9.79%
IDEXX Laboratories shares are trading lower after the company reported a Q3 revenue miss and issued guidance below estimates.
